EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)
Egypt · Delayed Price · Currency is EGP 331.99
+0.96 (0.29%)
At close: Oct 4, 2026
EGX:NIPH Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 16,600 | 1,465 | 699 | 405 | 359 | 354 | |
Market Cap Growth | 575.11% | 109.54% | 72.69% | 12.78% | 1.40% | 14.77% |
Enterprise Value | 17,932 | 2,282 | 1,009 | 670 | 317 | 305 |
Last Close Price | 331.99 | 32.01 | 16.84 | 9.08 | 7.38 | 6.76 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 69.13 | 11.65 | 7.75 | 3.40 | 4.00 | 5.50 |
PS Ratio | 7.41 | 1.14 | 0.61 | 0.40 | 0.41 | 0.47 |
PB Ratio | 15.04 | 1.97 | 1.49 | 0.85 | 0.83 | 0.95 |
P/TBV Ratio | 15.04 | 1.97 | 1.49 | 0.85 | 0.83 | 0.95 |
P/FCF Ratio | - | - | - | - | - | 4.72 |
P/OCF Ratio | - | 1568.74 | 2.65 | - | 73.13 | 4.46 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 8.01 | 1.77 | 0.88 | 0.67 | 0.36 | 0.40 |
EV/EBITDA Ratio | 27.72 | 7.41 | 6.49 | 1.36 | 2.28 | 2.84 |
EV/EBIT Ratio | 31.56 | 8.17 | 7.03 | 4.11 | 2.53 | 3.19 |
EV/FCF Ratio | - | - | - | - | - | 4.07 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 1.23 | 1.33 | 1.23 | 0.44 | 0.19 | 0.12 |
Debt / EBITDA Ratio | 2.09 | 3.21 | 3.70 | 0.43 | 0.57 | 0.40 |
Debt / FCF Ratio | - | - | - | - | - | 0.58 |
Net Debt / Equity Ratio | 1.21 | 1.30 | 1.15 | 0.40 | 0.06 | -0.18 |
Net Debt / EBITDA Ratio | 2.06 | 3.14 | 3.48 | 0.39 | 0.19 | -0.61 |
Net Debt / FCF Ratio | -1.86 | -2.04 | -3.48 | -0.67 | -0.60 | -0.88 |
Asset Turnover | 0.89 | 0.68 | 0.91 | 1.11 | 1.18 | 1.08 |
Inventory Turnover | 3.60 | 1.82 | 2.08 | 2.26 | 2.62 | 2.09 |
Quick Ratio | 0.64 | 0.38 | 0.35 | 0.47 | 0.57 | 0.74 |
Current Ratio | 1.13 | 0.98 | 1.28 | 1.75 | 1.81 | 1.75 |
Return on Equity (ROE) | 26.02% | 20.75% | 19.05% | 26.22% | 22.36% | 18.16% |
Return on Assets (ROA) | 14.09% | 9.20% | 7.14% | 11.25% | 10.53% | 8.54% |
Return on Invested Capital (ROIC) | 18.80% | 15.82% | 14.25% | 23.69% | 25.38% | 24.88% |
Return on Capital Employed (ROCE) | 36.60% | 25.00% | 17.80% | 30.10% | 28.90% | 25.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 1.45% | 8.58% | 12.90% | 29.44% | 24.98% | 18.19% |
FCF Yield | -4.32% | -32.28% | -22.25% | -70.16% | -12.21% | 21.21% |
Dividend Yield | 0.60% | 6.25% | 22.04% | 55.09% | 40.27% | 29.57% |
Payout Ratio | 41.64% | 39.41% | 71.36% | 34.95% | 37.13% | 70.73% |
Buyback Yield / Dilution | -66.67% | -196.30% | - | - | - | - |
Total Shareholder Return | -66.06% | -190.05% | 22.04% | 55.09% | 40.27% | 29.57% |